Growth in Leading Regional and National Markets – North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico

1. www.visiongain.com Page 81
Generic Drugs Market Forecast 2018-2028: Growth in Leading
Regional and National Markets – North America, Europe, Asia-
Pacific, Middle-East & Africa, Latin America, US, Canada, Germany,
France, UK, Italy, Spain, India, China, Australia, South Korea, Japan,
South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico
Figure 3.15 The Global Generic Drugs Market Drivers & Restraints, 2017-2028
We have defined some of the market drivers for growth in the global generic drugs market over the
forecast period. This list is not exhaustive as they will be examined closer into depth within the report
for each given region or country. Some of the factors identified include:
• Cost-pressures of branded drugs which encourages healthcare providers and governments
to introduce policies to encourage generic drugs use.
• Demographic trends: population growth, an increasing proportion of elderly people in most
countries, and the rapid emergence of the middle-class in many emerging markets will drive
demand for generic medicines.
• Expansion of healthcare provision in the US via the Affordable Care Act, China, India, Russia
and other major markets which increases the market for branded and generic drugs.
• Increased focus on higher-value generics, or the aforementioned ‘complex’ or differentiated
generics, as well as biosimilar drugs which still remain cheaper.
• Loss of patent protection of a number of major originator drugs.
Source: Visiongain 2018
6
• Demographic trends: population growth
and population ageing.
• Economic recovery and growth.
• Expansion of healthcare provision.
• Cost pressure driving volume growth.
• Strong political support for domestic
generic drug markets.
• High-value generics and biosimilars.
• Patent expiry of high-value drugs.
• Lower price of generics.
Drivers Restraints
• Decreasing pool of high-value originator
drugs over time.
• Shortages of drugs due to manufacturing
and supply problems.
• Concern over slow uptake of biosimilars.
• High competition driving down the prices
of all generics lowering profitability
reducing generic drug.

2. www.visiongain.com Page 116
Generic Drugs Market Forecast 2018-2028: Growth in Leading
Regional and National Markets – North America, Europe, Asia-
Pacific, Middle-East & Africa, Latin America, US, Canada, Germany,
France, UK, Italy, Spain, India, China, Australia, South Korea, Japan,
South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico
Table 5.5 Italy Generic Drugs Market Value ($bn), AGR (%) and CAGR (%),
2017 - 2028
Country 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
ItalyMarket($Billion) 3.9 4.2 4.9 5.4 6.2 6.7 7.6 8.2 8.8 10.0 10.6 11.9
AGR(%) 10.0 16.2 8.7 15.2 8.1 14.2 7.6 7.3 13.0 6.8 12.1
CAGR(%),2017-2022and2022-
2028
CAGR(%)2017-2028 10.8
11.6 10.1
Figure 5.5 Italy Generic Drugs Market Value ($bn) and AGR (%) 2017 - 2028
In 2017 the Italian generic drugs market was worth $3.9bn which we estimated to grow to $4.2bn in
2018 (Table 5.5). With the current low level of generic penetration in the country, we anticipate further
government regulations geared towards generic substitution to stimulate an increase in generic
penetration rates during the forecast period. Cost pressures and the residual effects of austerity in
the Eurozone will contribute to the development of this market. This combined with off-patent drugs
in the coming years bring prospect for the development of Italy’s young generic drug market.
We forecasted the generic drugs in the Italian market to grow from $3.9bn in 2017 to reach $6.7bn
in 2022 with a CAGR of 11.6% (Table 5.5 and Figure 5.5). We expect the political and regulatory
3.9
4.2
4.9
5.4
6.2
6.7
7.6
8.2
8.8
10.0
10.6
11.9
0.0
2.0
4.0
6.0
8.0
10.0
12.0
14.0
16.0
18.0
0.0
2.0
4.0
6.0
8.0
10.0
12.0
14.0
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
AGR(%)
Revenue($bn)
Year
Source: Visiongain 2018
2011-2014 figures
are estimated.
Source: Visiongain 2018
2011-2014 figures
are estimated.

3. www.visiongain.com Page 164
Generic Drugs Market Forecast 2018-2028: Growth in Leading
Regional and National Markets – North America, Europe, Asia-
Pacific, Middle-East & Africa, Latin America, US, Canada, Germany,
France, UK, Italy, Spain, India, China, Australia, South Korea, Japan,
South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico
Figure 8.6 Latin America Generic Drugs Market, % Country Share,
2022
Source: Visiongain 2018
Figure 8.7 Latin America Generic Drugs Market, % Country Share,
2028
Source: Visiongain 201
Brazil
39%
Argentina
12%
Mexico
22%
Rest of Latin
America
27%
Brazil
37%
Argentina
11%
Mexico
27%
Rest of Latin
America
25%